Testosterone NDC 70700-112

NDC codes

FDA NDC Directory

Product NDC (as listed)70700-112Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70700-0112Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70700-112-21	70700011221	1 BOTTLE, PUMP in 1 CARTON (70700-112-21) / 88 g in 1 BOTTLE, PUMPMarketed from May 8, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Testosterone
Generic name (nonproprietary): testosterone
Active ingredients: Testosterone — 20.25 mg/1.25g
Dosage form: Gel, Metered
Route: Transdermal
Labeler: Xiromed, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210835
Marketing start: May 8, 2020
Listing expires: Dec 31, 2027
DEA schedule: CIII
Other FDA classes: Androgen Receptor Agonists (Mechanism)Androstanes (Chemical structure)
Identifiers: Product ID 70700-112_28a07d51-b9bc-b13e-145d-56a5c6d50b4cSPL ID 28a07d51-b9bc-b13e-145d-56a5c6d50b4cSPL set ID 28e8d504-5073-1d78-f351-bcb7c5188ee6RxCUI 1597076UNII 3XMK78S47OUPC 0370700112212
Pharmacologic class: Androgen

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Transdermal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470700011221 followed by a unit qualifier and the quantity

Package 70700-0112-21. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 12, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Testosterone gel, 1.62% is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired): testicular failure due to conditions such as cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. These men usually have low serum testosterone concentrations and gonadotropins (follicle-stimulating hormone [FSH], luteinizing hormone [LH]) above the normal range. Hypogonadotropic hypogonadism (congenital or acquired): gonadotropin or luteinizing hormone-releasing hormone (LHR…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 210835

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210835
Product	Strength	Form · route	Labeler	Product NDC
Testosterone	Testosterone 20.25 mg/1.25g	Gel, MeteredTransdermal	Northstar Rx LLC	72603-265
Testosterone	Testosterone 20.25 mg/1.25g	Gel, MeteredTransdermal	Bryant Ranch Prepack	72162-1962
Testosterone	Testosterone 20.25 mg/1.25g	Gel, MeteredTransdermal	Bryant Ranch Prepack	63629-2352